Inactive Instrument

Highlights Yumanity Therapeutics

Equities

YMTX

US98872L1026

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Yumanity Therapeutics : Kineta Completes Reverse Merger with Yumanity Therapeutics - Form 8-K	22-12-22	PU
Kineta's Shares Gain Momentum on Nasdaq Debut Following Yumanity Therapeutics Reverse Merger Completion	22-12-19	MT
Kineta, Yumanity Therapeutics Complete Reverse Merger	22-12-19	MT
Kineta, Inc. completed the acquisition of Yumanity Therapeutics, Inc. from a group of shareholders in a reverse merger transaction.	22-12-15	CI
Daehan Green Power Corporation agreed to acquire 5.58% stake in Yumanity Therapeutics, Inc. for KRW 1.3 billion.	22-12-05	CI
Yumanity Therapeutics to Pay Special Cash Dividend Related to Planned Asset Sale, Kineta Merger -- Shares Rise	22-12-05	MT
Yumanity Therapeutics Declares Special Dividend In Connection with Proposed Asset Sale to Janssen and Merger with Kineta	22-12-05	GL
Yumanity Therapeutics Declares Special Dividend In Connection with Proposed Asset Sale to Janssen and Merger with Kineta	22-12-05	GL
Yumanity Therapeutics Declares Special Dividend, Payable in Cash on or Before December 29, 2022	22-12-05	CI
Yumanity Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Yumanity Therapeutics Announces Effectiveness of Registration Statement on Form S-4 In Connection With Proposed Asset Sale to Janssen and Merger with Kineta, Inc.	22-11-10	GL
Yumanity Therapeutics Announces Effectiveness of Registration Statement on Form S-4 In Connection With Proposed Asset Sale to Janssen and Merger with Kineta, Inc.	22-11-10	AQ
Yumanity Therapeutics Announces Filing of Registration Statement on Form S-4 In Connection With Proposed Asset Sale to Janssen and Merger with Kineta	22-08-29	AQ
Yumanity Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-04	CI
Earnings Flash (YMTX) YUMANITY THERAPEUTICS Reports Q2 Revenue $1.66M	22-08-04	MT
Yumanity to Merge With Kineta; Sells Drug Candidate to Janssen Unit for $26 Million; Shares Jump	22-06-06	MT
Yumanity to Sell Neurosciences Candidates, Merge With Kineta	22-06-06	DJ
Kineta, Inc. entered into definitive agreement to acquire Yumanity Therapeutics, Inc. from a group of shareholders in a reverse merger transaction.	22-06-05	CI
Yumanity Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-12	CI
Earnings Flash (YMTX) YUMANITY THERAPEUTICS Reports Q1 Revenue $1M	22-05-12	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Yumanity Therapeutics

Equities

YMTX

US98872L1026

Highlights

Filters